Differences Between Molecular and Genomic Biomarkers

The terms "molecular biomarker" and "genomic biomarker" refer to specific types of biomarkers used in the field of biomedicine for diagnosis, prognosis, and monitoring the response to treatment, among other applications. Both fall under the broader category of biomarkers, which are measurable indicators of some biological state or condition, but they differ in what they measure and represent.

• Molecular Biomarker

  A molecular biomarker refers to any molecule measured in tissues, cells, or bodily fluids that is a sign of a normal or abnormal process, or of a condition or disease. Molecular biomarkers can include a wide range of molecule types, such as:

  • Proteins/peptides: Changes in expression levels, modifications, or activity can serve as markers.
  • Lipids: Variations in lipid profiles can indicate metabolic states or diseases.
  • Metabolites: Small molecule byproducts of metabolic processes can indicate physiological or pathological states.
  • RNA: Variations in RNA expression levels, including mRNA and non-coding RNAs (like miRNA), can reflect gene expression changes in response to a disease or treatment.

  Molecular biomarkers thus encompass a broad range of biological molecules that reflect the state of biological processes or diseases.

• Genomic Biomarker

  A genomic biomarker specifically refers to a DNA sequence or genetic variation that provides information on an individual's characteristics, condition, disease risk, or response to treatment. Genomic biomarkers include:

  • Single nucleotide polymorphisms (SNPs): Single base-pair variations in the genome that can be associated with disease risk, drug response, or other traits.
  • Gene mutations: Alterations in DNA sequence that can be benign, or lead to disease.
  • Copy number variations (CNVs): Changes in the number of copies of a particular gene, which can affect gene expression levels and contribute to various diseases.
  • Epigenetic markers: Changes in gene expression or cellular phenotype caused by mechanisms other than changes in the DNA sequence itself, such as DNA methylation and histone modification.

  Genomic biomarkers are directly related to an individual's genetic information and provide insights into genetic predispositions, disease risks, and how an individual might respond to a drug or a treatment based on their genetic makeup.

The main difference between molecular and genomic biomarkers lies in their nature and the level at which they operate. Molecular biomarkers can be any type of molecule that indicates something about the state of the organism, often reflecting the effect of genetic variations, environmental factors, and their interactions. Genomic biomarkers, on the other hand, are specifically related to the genetic information (DNA or epigenetic modifications) of an individual, providing insights into genetic predispositions and the potential for disease or response to treatment. Both types of biomarkers are crucial for personalized medicine, allowing for tailored treatments based on individual molecular and genetic profiles.

Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer https://www.mdpi.com/1422-0067/23/7/3968

like unlike

点赞本文的读者

还没有人对此文章表态

本文有评论

没有评论

看文章，发评论，不要沉默